COMMUNIQUÉS West-GlobeNewswire

Tabula Rasa HealthCare to Participate in Upcoming Investor Conference
14/11/2018
MOORESTOWN, N.J., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, today announced that Chief Financial [...]
CareDx Announces Pricing of Public Offering of Common Stock
14/11/2018
BRISBANE, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value [...]
Innovate Biopharmaceuticals Reports Third Quarter 2018 Earnings and Key Corporate Highlights
13/11/2018
Poster presentation at the American Association of Study of Liver Diseases showing promising pre-clinical data of larazotide acetate in NASH reducing intestinal permeability. Innovate plans to initiate a Phase 2 [...]
Loop Industries Closes $2.45M Private Placement
13/11/2018
MONTREAL, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Loop Industries, Inc. (Nasdaq: LOOP ) ("Loop" or the "Company"), a leading technology innovator in sustainable plastic, today announced the closing of a private placement [...]
Helix BioPharma Corp. Provides Strategic Update on L-DOS47 Clinical Program
13/11/2018
RICHMOND HILL, Ontario, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: “HBP”), an immuno-oncology company developing drug candidates for the prevention and treatment of cancer, provides a strategic [...]
Loop Industries Announces Change of CFO
13/11/2018
MONTREAL, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Loop Industries (Nasdaq:LOOP) (“Loop” or “Company”), a leading technology innovator in sustainable plastic resin and polyester fiber, today announced that CFO Frank Zitella [...]
Delcath Announces Third Quarter Fiscal 2018 Financial Results
13/11/2018
NEW YORK, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces financial results for the [...]
Altimmune Announces Third Quarter 2018 Financial Results and Provides Corporate Update
13/11/2018
GAITHERSBURG, Md., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage immunotherapeutics company, today announced financial results for the three and nine months ended September 30, 2018. [...]
Zomedica Pharmaceuticals Corp. Announces Third Quarter 2018 Financial Results
13/11/2018
ANN ARBOR, Mich., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company, today reported [...]
National Brain Tumor Society Supported Work Features in 19 Presentations at 2018 Society for Neuro-Oncology Annual Meeting
13/11/2018
Boston, MA, Nov. 13, 2018 (GLOBE NEWSWIRE) -- National Brain Tumor Society (NBTS), the largest nonprofit dedicated to the brain tumor community in the United States, today announced that its funded research, programs, [...]
Molecular Templates, Inc. Reports Third Quarter 2018 Financial Results and Provides Corporate Update
13/11/2018
AUSTIN, Texas, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular” or “Molecular Templates”), a clinical-stage oncology company focused on the discovery and development of the company’ [...]
Adverum to Present at 30th Annual Piper Jaffray Healthcare Conference
13/11/2018
MENLO PARK, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ophthalmology and rare diseases, today announced [...]
Alcon files initial Form 20-F registration statement with SEC for proposed spinoff; plans investor days in New York and London
13/11/2018
Basel, November 13, 2018 - Novartis today announced that Alcon has filed an initial Form 20-F registration statement with the US Securities and Exchange Commission (SEC) in relation to the previously-announced intention [...]
Mustang Bio Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights
13/11/2018
NEW YORK, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a company focused on the development of novel immunotherapies based on proprietary chimeric antigen receptor engineered T cell (“ [...]
Homology Medicines Reports Third Quarter 2018 Financial Results
13/11/2018
On Track to Begin and Report Initial Clinical Data from PKU Gene Therapy Trial and to Start IND-Enabling Studies in PKU Gene Editing and MLD Gene Therapy Programs Next Year BEDFORD, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE [...]
Teligent, Inc. Announces Third Quarter 2018 Results
13/11/2018
BUENA, N.J., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (the "Company"), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the third quarter [...]
Teligent, Inc. Announces $120 Million Financing Commitment From Ares
13/11/2018
BUENA, N.J., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), (“Teligent” or the “Company”) announced today that the Company secured a financing commitment from funds managed by Ares Management, L.P. (“ [...]
Resonant Inc. Reports Third Quarter 2018 Financial Results and Provides Business Update
13/11/2018
GOLETA, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for mobile handset and wireless [...]
electroCore, Inc. Announces Third Quarter Financial Results
13/11/2018
BASKING RIDGE, N.J., Nov. 13, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (“electroCore”) (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today reported financial results for the three months and nine [...]

Pages